Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP352003.RAWE18Y09KPtd4QijdqGPK2xKXQlxwEocOo1IwTFlSyDc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP352003.RAWE18Y09KPtd4QijdqGPK2xKXQlxwEocOo1IwTFlSyDc130_assertion type Assertion NP352003.RAWE18Y09KPtd4QijdqGPK2xKXQlxwEocOo1IwTFlSyDc130_head.
- NP352003.RAWE18Y09KPtd4QijdqGPK2xKXQlxwEocOo1IwTFlSyDc130_assertion description "[The administration of an agonistic anti-4-1BB antibody (2A) dramatically reduced the incidence and severity of experimental autoimmune encephalomyelitis (EAE).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352003.RAWE18Y09KPtd4QijdqGPK2xKXQlxwEocOo1IwTFlSyDc130_provenance.
- NP352003.RAWE18Y09KPtd4QijdqGPK2xKXQlxwEocOo1IwTFlSyDc130_assertion evidence source_evidence_literature NP352003.RAWE18Y09KPtd4QijdqGPK2xKXQlxwEocOo1IwTFlSyDc130_provenance.
- NP352003.RAWE18Y09KPtd4QijdqGPK2xKXQlxwEocOo1IwTFlSyDc130_assertion SIO_000772 14599849 NP352003.RAWE18Y09KPtd4QijdqGPK2xKXQlxwEocOo1IwTFlSyDc130_provenance.
- NP352003.RAWE18Y09KPtd4QijdqGPK2xKXQlxwEocOo1IwTFlSyDc130_assertion wasDerivedFrom befree-20140225 NP352003.RAWE18Y09KPtd4QijdqGPK2xKXQlxwEocOo1IwTFlSyDc130_provenance.
- NP352003.RAWE18Y09KPtd4QijdqGPK2xKXQlxwEocOo1IwTFlSyDc130_assertion wasGeneratedBy ECO_0000203 NP352003.RAWE18Y09KPtd4QijdqGPK2xKXQlxwEocOo1IwTFlSyDc130_provenance.